HemoRel-A Injection

Overview HemoRel-A Injection

Factor VIII replacement therapy, HemoRel-A Injection, manages and prevents hemorrhage in individuals with hemophilia A, an inherited clotting deficiency. It acts by supplementing the missing Factor VIII, enabling clot formation at bleeding sites. Administration must be intravenous and performed by a qualified healthcare provider. Report any allergies to this medication to your physician. Potential adverse reactions include chills, facial flushing, skin rashes, and epistaxis. Persistent side effects warrant medical attention. Liver impairment necessitates dose modification; inform your doctor if affected. Discuss driving suitability and alcohol consumption post-injection with your doctor. Disclose pregnancy, breastfeeding, or kidney disease to your physician before treatment.

Uses of HemoRel-A Injection

Classical hemophilia

Major Benefits of HemoRel-A Injection:

Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of HemoRel-A Injection:

• Chills
• Flushing (sense of warmth in the face, ears, neck and trunk)
• Rash
• Nosebleeds

How to use HemoRel-A Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How HemoRel-A Injection works:

Hemophilia A patients require HemoRel-A Injection to facilitate blood clot formation and hemostasis, thereby preventing hemorrhage.

What if you forget to take HemoRel-A Injection :

Omit a dose of HemoRel-A Injection? Seek your physician's advice.